RetractedArticleFrontiers in oncology2020

CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer.

Tongyi Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.